Jan-petter Larsen
#147,557
Most Influential Person Now
Jan-petter Larsen's AcademicInfluence.com Rankings
Jan-petter Larsenbiology Degrees
Biology
#10802
World Rank
#14159
Historical Rank
Neuroscience
#1703
World Rank
#1757
Historical Rank
Download Badge
Biology
Why Is Jan-petter Larsen Influential?
(Suggest an Edit or Addition)Jan-petter Larsen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. (2003) (1301)
- Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study (2000) (699)
- Cognitive impairment in incident, untreated Parkinson disease (2009) (589)
- Range of neuropsychiatric disturbances in patients with Parkinson’s disease (1999) (578)
- Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia (2006) (568)
- Risk of dementia in Parkinson’s disease (2001) (484)
- The occurrence of depression in Parkinson's disease. A community-based study. (1996) (447)
- Mild cognitive impairment in Parkinson disease (2010) (443)
- A community‐based study of sleep disorders in patients with Parkinson's disease (1998) (443)
- Dementia and survival in Parkinson disease (2008) (400)
- Changes in motor subtype and risk for incident dementia in Parkinson's disease (2006) (397)
- MRI evaluation of the size and symmetry of the planum temporale in adolescents with developmental dyslexia (1990) (352)
- Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease (1999) (345)
- Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study (2002) (339)
- Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study (2005) (335)
- Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. (1999) (335)
- A 12-year population-based study of psychosis in Parkinson disease. (2010) (333)
- Health related quality of life in Parkinson's disease: a prospective longitudinal study (2000) (321)
- Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations (1998) (316)
- Differences in neuropathologic characteristics across the Lewy body dementia spectrum (2006) (308)
- A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia (2001) (302)
- Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. (2013) (300)
- Frequency of dementia in Parkinson disease. (1996) (291)
- Fatigue in patients with Parkinson's disease (1999) (280)
- Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community‐based study (1999) (279)
- Risk of dementia in Parkinson’s disease: A community-based, prospective study (2001) (269)
- The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease (2009) (266)
- The rate of cognitive decline in Parkinson disease. (2004) (256)
- Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease (2006) (256)
- A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry (2006) (255)
- Progression of motor impairment and disability in Parkinson disease (2005) (248)
- What predicts mortality in Parkinson disease? (2010) (246)
- Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study (2009) (230)
- Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease (2003) (225)
- Epidemiology of Parkinson’s disease (2008) (224)
- Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time (2007) (219)
- Neuropsychological Profile of Patients with Parkinson’s Disease without Dementia (2003) (218)
- Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment (2005) (207)
- Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia (2003) (201)
- CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study (2010) (201)
- Is fatigue an independent and persistent symptom in patients with Parkinson disease? (2004) (200)
- Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. (2005) (197)
- The epidemiology of Parkinson's disease in the county of Rogaland, Norway (1995) (197)
- Risk factors for depression in Parkinson disease. (1997) (192)
- Insomnia in Parkinson’s disease: frequency and progression over time (2006) (186)
- Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. (2001) (186)
- Cognitive Predictors of Dementia in Parkinson’s Disease: A Community-Based, 4-Year Longitudinal Study (2005) (185)
- Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study (2009) (185)
- Predictors and course of health‐related quality of life in Parkinson's disease (2008) (181)
- Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease (2016) (179)
- Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. (2013) (175)
- Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. (2009) (162)
- Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies (2007) (160)
- Fluctuations in attention (2002) (160)
- Development of daytime somnolence over time in Parkinson’s disease (2002) (159)
- Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms (2007) (153)
- The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease (2015) (151)
- The effect of age of onset of PD on risk of dementia (2007) (148)
- Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study (2014) (147)
- Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia (2010) (147)
- A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson’s disease (1999) (145)
- Excessive daytime sleepiness in Parkinson disease (2006) (142)
- Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease (2001) (142)
- Natural course of mild cognitive impairment in Parkinson disease (2017) (141)
- CSF Aβ42 predicts early-onset dementia in Parkinson disease (2014) (139)
- Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation (2006) (123)
- Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's disease (2006) (119)
- Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease (2013) (113)
- Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study (2009) (109)
- Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease (2006) (108)
- Visual rating of white matter hyperintensities in Parkinson's disease (2006) (102)
- Quality of life measurements in patients with Parkinson's disease: A community‐based study (1998) (100)
- Development of excessive daytime sleepiness in early Parkinson disease (2015) (100)
- Does selegiline modify the progression of early Parkinson's disease? Results from a five‐year study (1999) (97)
- The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation (2010) (97)
- The economic impact of cognitive impairment in Parkinson's disease (2011) (97)
- Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study (2005) (96)
- microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases (2016) (95)
- Effect of selegiline on mortality in patients with Parkinson's disease (1998) (93)
- A 12-year population-based study of freezing of gait in Parkinson's disease. (2015) (92)
- Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. (2011) (91)
- Pain and its relationship to depression in Parkinson disease. (2009) (89)
- Cigarette smoking in Parkinson's disease: Influence on disease progression (2004) (89)
- Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study (2010) (88)
- Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild (2011) (88)
- Patient information and coping styles in multiple sclerosis (2007) (87)
- Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-induced Cytotoxicity* (2013) (86)
- Risk and course of motor complications in a population-based incident Parkinson's disease cohort. (2016) (82)
- Magnetic resonance imaging of the corpus callosum in developmental dyslexia (1992) (79)
- Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease (2012) (78)
- Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. (2006) (78)
- Sleep Disorders in Patients with Parkinson’s Disease (2001) (76)
- Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia (2005) (75)
- Health related quality of life in patients recently diagnosed with multiple sclerosis (2014) (74)
- Parkinson's disease and age: The obvious but largely unexplored link (2015) (72)
- Western Norway, a high‐risk area for multiple sclerosis (1984) (71)
- Olanzapine for psychosis in patients with Parkinson's disease with and without dementia. (1999) (70)
- Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: A nested, case‐control study (2012) (68)
- Multiple sclerosis – more than one disease? (1985) (67)
- Gray matter correlations of cognition in incident Parkinson's disease (2010) (66)
- Prevalence of low back and pelvic pain during pregnancy in a Norwegian population. (2012) (64)
- Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. (1988) (64)
- White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease (2009) (64)
- Mortality and Parkinson disease (2004) (64)
- Epidemiology of the Guillain‐Barré syndrome in the county of Hordaland, Western Norway (1985) (63)
- Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment (2012) (63)
- Fatigue in early Parkinson’s disease. Minor inconvenience or major distress? (2012) (62)
- Prognostic factors and survival in amyotrophic lateral sclerosis. (1994) (62)
- Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease (2012) (61)
- Disturbance of automatic auditory change detection in dementia associated with Parkinson's disease: A mismatch negativity study (2010) (60)
- Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer type. (1994) (57)
- Coping with multiple sclerosis: a 5‐year follow‐up study (2009) (57)
- Ventricular enlargement and mild cognitive impairment in early Parkinson's disease (2011) (57)
- APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study (2009) (56)
- Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease (2001) (55)
- Psychometric properties of the Starkstein Apathy Scale in patients with early untreated Parkinson disease. (2012) (54)
- Parkinson's disease as community health problem: study in Norwegian nursing homes. The Norwegian Study Group of Parkinson's Disease in the Elderly. (1991) (52)
- Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern. (1991) (50)
- Fine mapping and resequencing of the PARK16 locus in Parkinson’s disease (2015) (50)
- Brain atrophy and white matter hyperintensities in early Parkinson's disease (2009) (49)
- The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal (2017) (49)
- Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis (1999) (47)
- Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. (2001) (46)
- An increase in the incidence of multiple sclerosis in Western Norway (1984) (43)
- Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study (2016) (43)
- Natural history of falls in a population-based cohort of patients with Parkinson's disease: an 8-year prospective study. (2014) (42)
- Magnetic resonance imaging ‐ a method of studying the size and asymmetry of the planum temporale (1989) (42)
- Changes in insomnia subtypes in early Parkinson disease (2017) (42)
- Maintenance electroconvulsive therapy for Parkinson's disease. (1997) (42)
- The effects of early selegiline therapy on long‐term levodopa treatment and parkinsonian disability: An interim analysis of a norwegian–danish 5‐year study (1997) (41)
- Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease (2006) (40)
- Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism (2006) (40)
- Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson’s Disease Dementia (2008) (40)
- Clinical problems in non‐fluctuating patients with Parkinson's disease: A community‐based study (2000) (39)
- Mapping cortical atrophy in Parkinson's disease patients with dementia. (2013) (39)
- Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress (2015) (38)
- Loss of independence in early Parkinson disease (2016) (36)
- FMR1 Alleles in Parkinson's Disease: Relation to Cognitive Decline and Hallucinations, A Longitudinal Study (2007) (36)
- Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations (1996) (36)
- Disorders of motivation, sexual conduct, and sleep in Parkinson's disease. (2005) (35)
- Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. (2008) (35)
- Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial (1997) (34)
- LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation (2016) (33)
- The association between pelvic girdle pain and sick leave during pregnancy; a retrospective study of a Norwegian population (2015) (33)
- Progressive Degeneration of Dopaminergic Neurons through TRP Channel-Induced Cell Death (2014) (32)
- Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease (2013) (30)
- Pelvic girdle pain 3–6 months after delivery in an unselected cohort of Norwegian women (2016) (29)
- Familial Occurrence of Dementia and Parkinsonism (2006) (28)
- Reactive Oxygen Species-Mediated DJ-1 Monomerization Modulates Intracellular Trafficking Involving Karyopherin β2 (2014) (27)
- Re-admissions to hospital and patient satisfaction among patients with chronic obstructive pulmonary disease after telemedicine video consultation - a retrospective pilot study (2014) (27)
- Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson’s disease (2016) (27)
- Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons (2014) (26)
- Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. (2012) (25)
- Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis. (1999) (25)
- Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease (2018) (25)
- Prevalence and Characteristics of Dementia in Parkinson Disease (2015) (25)
- Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community‐based, longitudinal study (2006) (24)
- Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients (2010) (23)
- Combinatory microRNA serum signatures as classifiers of Parkinson's disease. (2019) (23)
- Long-term risk of falls in an incident Parkinson’s disease cohort: the Norwegian ParkWest study (2017) (23)
- A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells (2015) (23)
- Impact of Falls on Physical Activity in People with Parkinson's Disease. (2016) (23)
- Long-Term Mortality and Its Risk Factors in Stroke Survivors. (2016) (22)
- New Insight into Neurodegeneration: the Role of Proteomics (2014) (21)
- Reliability of Three Disability Scales for Detection of Independence Loss in Parkinson's Disease (2016) (20)
- Comorbid and underlying diseases—Major determinants of excess mortality in epilepsy (2012) (20)
- DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis (2017) (20)
- Subjective sleep problems in patients with early Parkinson's disease (2012) (20)
- Arabidopsis AtPARK13, Which Confers Thermotolerance, Targets Misfolded Proteins* (2014) (20)
- Are dysautonomic and sensory symptoms present in early Parkinson’s disease? (2010) (18)
- Endovascular Acute Stroke Treatment Performed by Vascular Interventional Radiologists: Is It Safe and Efficacious? (2012) (18)
- Parkinson disease: associated disorders in the Norwegian population based incident ParkWest study. (2013) (18)
- Health State Values during the First Year of Drug Treatment in Early-Stage Parkinson’s Disease (2009) (17)
- Multiple sclerosis and mortality statistics (1985) (17)
- Development and validation of prognostic survival models in newly diagnosed Parkinson's disease (2017) (17)
- Sleep disorders in Parkinson's disease. (2003) (15)
- Profiles of reading related skills in dyslexic families (1989) (15)
- Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population (2015) (14)
- The effect of tolcapone on the pharmacokinetics of benserazide (1999) (14)
- HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia (2015) (14)
- Lexical and Nonlexical Spelling Deficits in Dementia of the Alzheimer Type (1996) (13)
- PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons (2014) (12)
- The natural history of depressive symptoms in patients with incident Parkinson’s disease: a prospective cohort study (2017) (11)
- The Potential of Proteomics in Understanding Neurodegeneration. (2015) (11)
- [Neuropsychiatric and cognitive symptoms in Parkinson disease]. (2008) (11)
- Impact of exercise programs among helicopter pilots with transient LBP (2017) (10)
- Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations (2005) (10)
- Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia (2017) (10)
- Subjective recovery from pregnancy-related pelvic girdle pain the first 6 weeks after delivery: a prospective longitudinal cohort study (2020) (10)
- The factor structure of the UPDRS motor scores changes during early Parkinson's disease. (2014) (8)
- Subcellular Parkinson’s Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration (2017) (8)
- [Motor symptoms in Parkinson disease]. (2008) (8)
- a2-Adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson disease and depression (2000) (8)
- Validation of a new assay for α-synuclein detection in cerebrospinal fluid (2017) (7)
- Recurrent and Transient Spinal Pain Among Commercial Helicopter Pilots. (2015) (7)
- Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease (2017) (7)
- Chiropractic management of dominating one-sided pelvic girdle pain in pregnant women; a randomized controlled trial (2017) (5)
- Long-term effects of exercise programs among helicopter pilots with flying related LBP (2017) (5)
- Diagnosis and Treatment of Hallucinations and Delusions in Parkinson’s Disease (2003) (4)
- Treatment with statins improves long-term survival in individuals with carotid artery stenosis. (2013) (4)
- Can a bothersome course of pelvic pain from mid-pregnancy to birth be predicted? A Norwegian prospective longitudinal SMS-Track study (2018) (4)
- [abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease (2003) (4)
- morphometry impairment and dementia using voxel-based with Parkinson ’ s disease with mild cognitive A magnetic resonance imaging study of patients (2007) (4)
- Frequency and profile of mild cognitive impairment in Parkinson's disease: A multicentre meta-analysis of neuropsychological data (2009) (3)
- Biomarkers for cognitive impairment and dementia in Parkinson’s disease (2015) (3)
- [Nursing homes patients with Parkinson disease: diagnosis]. (1988) (3)
- A Scandinavian multi-centre study replicates 11 susceptibility loci from genome-wide association studies in Parkinson's disease (2012) (3)
- Granulocyte function in patients with multiple sclerosis. (2009) (3)
- Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study (2005) (3)
- Immune disorders and dyslexia (1994) (3)
- Neurointerventional Treatment in Acute Stroke. Whom to Treat? (Endovascular Treatment for Acute Stroke: Utility of THRIVE Score and HIAT Score for Patient Selection) (2013) (3)
- Patient Characteristics, MRI Examination, and Dopaminergic Drug Response in Clinical Possible Parkinson's Disease (1996) (2)
- DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis (2017) (2)
- Memory impairment is associated with hippocampal atrophy in newly diagnosed Parkinson's disease (2011) (2)
- Rate of cognitive decline in PD (2006) (2)
- [Nursing homes patients with Parkinson disease: treatment]. (1988) (2)
- [Electroconvulsive treatment in parkinsonism]. (1993) (1)
- [Emotional and cognitive disorders in Parkinson disease]. (1998) (1)
- 2.271 Wearing-off symptoms in Parkinson's disease – the patient perspective: A nationwide survey in Norway (2007) (1)
- Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons (2014) (1)
- A tensor based morphometry study of patients with cognitive impairment and dementia in parkinson's disease (2009) (1)
- Consistent message? (2012) (1)
- [Diagnosis and treatment of patients with parkinsonism in nursing homes: how to improve quality?]. (2005) (1)
- Epidemiological Studies of Multiple Sclerosis in Western Norway: Possible Factors in Etiology and Prognosis (1988) (1)
- [Treatment of Parkinson disease with levodopa depot preparations]. (1991) (1)
- Adding Chiropractic Treatment to Individual Rehabilitation for Persistent Pelvic Girdle Pain 3 to 6 Months After Delivery: A Pilot Randomized Trial. (2019) (1)
- Association of GBA polymorphisms and mutations with dementia in incident Parkinson disease (2018) (1)
- Environmental Predictors of Cognitive Impairment in Parkinson’s Disease (P5.237) (2014) (0)
- DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL OF MORTALITY IN PD (2016) (0)
- T-L-089 CHANGE OF RLS IN PATIENTSWITH EARLY PARKINSONS DISEASE AFTER ONE YEAR OF DOPAMINERGIC TREATMENT (2011) (0)
- miR‐153‐3p And miR‐205‐5p Target Key Regulatory Pathways in Neuronal Cells (2015) (0)
- Fluctuations in attention: PD dementia vs DLB with parkinsonism (2002) (0)
- P1-217: Automated 3D mapping of caudate atrophy and ventricular enlargement in Parkinson's disease with and without dementia (2008) (0)
- PNM17 RETROSPECTIVE EVALUATION OF THE DOSE OF DYSPORT® AND BOTOX® IN THE CLINICAL MANAGEMENT OF CERVICAL DYSTONIA OR BLEPHAROSPASM—COST CONSIDERATIONS FOR THE REAL DOSE STUDY (2003) (0)
- CSF Abeta and tau, hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease with and without mild cognitive impairment (2010) (0)
- Hippocampal Atrophy and Lateral Ventricle Enlargement in Parkinson's Disease Subjects with Mild Cognitive Impairment (2010) (0)
- [Magnetic resonance tomography in the diagnosis of multiple sclerosis]. (1987) (0)
- microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases (2015) (0)
- Chapter 17. Early (Uncomplicated) Parkinson's Disease (2008) (0)
- [Magnetic resonance. Diagnosis of tumors of the nervous system]. (1987) (0)
- Information-Processing Obstacles in Reading Acquisition (1989) (0)
- P2-226: Association of proteasome subunit expression with reduced proteolytic activity in dementia with Lewy bodies and Parkinson's disease dementia (2008) (0)
- [Movement disorders--what should be done?]. (2008) (0)
- October 2, 1986: MRI in the diagnosis of central nervous system tumors (1987) (0)
- Chapter 18. Late (Complicated) Parkinson's Disease (2008) (0)
- Protects against Metal-induced Parkinson Disease Protein DJ-1 Binds Molecular Bases of Disease : (2013) (0)
- Course and prognostic significance of performance in reading, spelling and oral language in Alzheimer's disease (1996) (0)
- New Insight into Neurodegeneration: the Role of Proteomics (2013) (0)
- Excessive daytime sleepiness in early Parkinson’s disease: a 5 year follow-up (2013) (0)
- Epidemiological studies on multiple sclerosis (1985) (0)
- Paper II Is fatigue an independent and persistent symptom in patients with Parkinson disease? (2006) (0)
- II.P1 Mild cognitive impairment in Parkinson's Disease - an MRI study (2006) (0)
- Olanaapin for psychosis in patients with Parkinson's disease with and without dementia (1998) (0)
- [Differential diagnosis in parkinsonism]. (1995) (0)
- P3-087: Neuropsychiatric correlates of CSF Tau and P-Tau in dementia (2008) (0)
- [Magnetic resonance imaging of the central nervous system]. (1987) (0)
- Memory impairment is associated with hippocampal atrophy in newly diagnosed Parkinson's disease (2011) (0)
- Parkinson ’ s Disease Population-based Studies on the Clinical Progression of Motor and Non-motor Features in Parkinson ’ s Disease (2009) (0)
- III.P4 REM Sleep behaviour disorder predicts visual hallucinations in Parkinson's Disease (2006) (0)
- Association of proteasome subunit expression with reduced proteolytic activity in dementia with Lewy bodies and Parkinson's disease dementia (2008) (0)
- [Explosion injury. Cardiopulmonary changes in extensive soft tissue injury and blast lung]. (1987) (0)
- Treatment with l-dopa normalize learning as measured with CVLT-2 in drug naive patients with Parkinson’s disease (2016) (0)
- Paper III Progression of motor impairment and disability in Parkinson disease A population-based study (2006) (0)
- Subcellular Parkinson’s Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration (2016) (0)
- [Magnetic resonance tomography. Diagnosis of tumors of the central nervous system]. (1987) (0)
- Hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease subjects with mild cognitive impairment (2010) (0)
- Validation of an electrochemiluminescent-based assay for α-Synuclein detection in cerebrospinal fluid (2017) (0)
- P3-394 The course of mild cognitive impairment in patients with Parkinson's disease (2004) (0)
- CSF Abeta and tau, hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease with and without mild cognitive impairment (2010) (0)
- Reactive Oxygen Species-Mediated DJ-1 Monomerization Modulates Intracellular Trafficking Involving Karyopherin (cid:2) 2 (2014) (0)
- PNL15 RETROSPECTIVE EVALUATION OF THE DOSE OF DYSPORTÒ AND BOTOXÒ IN THE CLINICAL MANAGEMENT OF CERVICAL DYSTONIA OR BLEPHAROSPASM—THE REAL DOSE STUDY EXPANSION—COST CONSIDERATIONS BASED ON DRUG START (2004) (0)
- Alfa-2-adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson's disease and depression (1999) (0)
- Hippocampal Atrophy and Lateral Ventricle Enlargement in Parkinson's Disease Subjects With Mild Cognitive Impairment (2010) (0)
- IC-P2-072: Automated 3D mapping of caudate atrophy and ventricular enlargement in Parkinson's disease with and without dementia (2008) (0)
- [Necrosis of a finger after radial artery cannulation]. (1977) (0)
- [Resuscitation of a critically wounded patient]. (1977) (0)
- A tensor-based morphometry study of patients with cognitive impairment and dementia in Parkinson's disease (2009) (0)
- Population-based Studies on the Clinical Progression of Motor and Non-motor Features in Parkinson’s Disease (2009) (0)
- [Burns caused by simulataneous use of diathermy and ECG]. (1975) (0)
- [Polyneuropathy as the first sign of osteosclerotic plasmacytoma]. (1984) (0)
- morphometryand dementia using voxel-based with Parkinson's disease with mild cognitive A magnetic resonance imaging study of patients (2009) (0)
- Chronic idiopathic polyneuropathy: Patients' own perception of well-being in correlation to clinical condition (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jan-petter Larsen?
Jan-petter Larsen is affiliated with the following schools:
